Loading
Latest filing published 25 Aug 2023 for Windtree Therapeutics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Eric Curtis (chief executive) discloses dealings in Windtree Therapeutics Inc to SEC (Form 4). Between 4 March 2022 and 23 August 2023, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 25 August 2023 with a share grant in Windtree Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations